Literature DB >> 24080949

Cochlear function among HIV-seropositive and HIV-seronegative men and women.

Peter Torre1, Howard J Hoffman, Gayle Springer, Christopher Cox, Mary Young, Joseph B Margolick, Michael Plankey.   

Abstract

OBJECTIVES: There is limited research about cochlear function in adults who are human immunodeficiency virus (HIV) positive (+). The aim of the present study was to collect measures of cochlear function in a large sample of adults with, or at risk for, HIV infection, to evaluate associations between HIV status, HIV treatment, and cochlear function.
DESIGN: Distortion product otoacoustic emissions (DPOAEs) were used to evaluate cochlear function in 506 participants; 329 men, 150 of whom were HIV+, and 177 women, 136 of whom were HIV+. DPOAEs were measured at frequencies 1000, 2000, 3000, 4000, and 6000 Hz. A DPOAE nonresponse (NR) was defined as an absolute DPOAE level less than -15 dB SPL or a difference between the absolute DPOAE level and the background noise level less than 6 dB. The total number of NRs was calculated for each ear. The associations of demographic variables, HIV status, and HIV treatment with number of NRs were evaluated with univariate and multivariate ordinal regression models.
RESULTS: There was a statistically significant increase in the odds of higher numbers of NRs with age, being male, and being non-Black, but not with HIV status. Among HIV+ participants, there were no statistically significant associations of the HIV disease status or treatment variables with higher number of NRs.
CONCLUSION: The authors found no evidence of impaired cochlear function by HIV disease status or highly active antiretroviral therapy-treated HIV infection in this cross-sectional study.

Entities:  

Mesh:

Year:  2014        PMID: 24080949      PMCID: PMC3872496          DOI: 10.1097/AUD.0b013e3182a021c8

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  23 in total

1.  Distortion product emissions in humans. I. Basic properties in normally hearing subjects.

Authors:  B L Lonsbury-Martin; F P Harris; B B Stagner; M D Hawkins; G K Martin
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1990-05

Review 2.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Distortion-Product Otoacoustic Emissions as a Screening Tool for Noise-Induced Hearing Loss.

Authors:  Lynne Marshall; Judy A. Lapsley Miller; Laurie M. Heller
Journal:  Noise Health       Date:  2001       Impact factor: 0.867

4.  Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.

Authors: 
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

5.  Stimulated acoustic emissions from within the human auditory system.

Authors:  D T Kemp
Journal:  J Acoust Soc Am       Date:  1978-11       Impact factor: 1.840

6.  On the detection of early cochlear damage by otoacoustic emission analysis.

Authors:  M Lucertini; A Moleti; R Sisto
Journal:  J Acoust Soc Am       Date:  2002-02       Impact factor: 1.840

7.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

8.  Otologic disease in patients with acquired immunodeficiency syndrome.

Authors:  D Kohan; S G Rothstein; N L Cohen
Journal:  Ann Otol Rhinol Laryngol       Date:  1988 Nov-Dec       Impact factor: 1.547

9.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years.

Authors:  J Dudley; S Jin; D Hoover; S Metz; R Thackeray; J Chmiel
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

10.  Highly active antiretroviral therapy: Does it Sound toxic?

Authors:  Katijah Khoza-Shangase
Journal:  J Pharm Bioallied Sci       Date:  2011-01
View more
  7 in total

1.  Speech audiometry findings from HIV+ and HIV- adults in the MACS and WIHS longitudinal cohort studies.

Authors:  Peter Torre; Howard J Hoffman; Gayle Springer; Christopher Cox; Mary A Young; Joseph B Margolick; Michael Plankey
Journal:  J Commun Disord       Date:  2016-07-25       Impact factor: 2.288

2.  Distortion product otoacoustic emission data in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents in the Pediatric HIV/AIDS Cohort Study.

Authors:  Peter Torre; Tzy-Jyun Yao; Bret Zeldow; Paige Williams; Howard J Hoffman; George K Siberry
Journal:  Pediatr Infect Dis J       Date:  2015-03       Impact factor: 2.129

3.  Peripheral Auditory Function in Young HIV-Positive Adults With Clinically Normal Hearing.

Authors:  Christopher E Niemczak; Travis White-Schwoch; Abigail Fellows; Albert Magohe; Jiang Gui; Catherine Rieke; Trent Nicol; Enica R Massawe; Ndeserua Moshi; Nina Kraus; Jay C Buckey
Journal:  Otolaryngol Head Neck Surg       Date:  2021-09-21       Impact factor: 5.591

4.  Fall frequency and associated factors among men and women with or at risk for HIV infection.

Authors:  K M Erlandson; M W Plankey; G Springer; H S Cohen; C Cox; H J Hoffman; M T Yin; T T Brown
Journal:  HIV Med       Date:  2016-11       Impact factor: 3.180

5.  Auditory Impairments in HIV-Infected Children.

Authors:  Isaac I Maro; Abigail M Fellows; Odile H Clavier; Jiang Gui; Catherine C Rieke; Jed C Wilbur; Robert D Chambers; Benjamin G Jastrzembski; John E Mascari; Muhammad Bakari; Mecky Matee; Frank E Musiek; Richard D Waddell; C Fordham von Reyn; Paul E Palumbo; Ndeserua Moshi; Jay C Buckey
Journal:  Ear Hear       Date:  2016 Jul-Aug       Impact factor: 3.570

Review 6.  Main Aspects of Peripheral and Central Hearing System Involvement in Unexplained HIV-Related Hearing Complaints.

Authors:  Marrigje Aagje de Jong; Ari Luder; Menachem Gross
Journal:  Front Neurol       Date:  2019-08-06       Impact factor: 4.003

7.  Oxidative Stress as a Risk Factor for Hearing Changes in HIV-positive Normal Listeners.

Authors:  Carla G Matas; Fernanda Yasmin Omm Padilha; Rosanna Mg Angrisani; Alessandra G Samelli
Journal:  Clinics (Sao Paulo)       Date:  2020-11-27       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.